Physician profile
Stephanie Spirawk
NPI 1275925505
$330.60
in general payments reported to CMS, 2019-2025
10 companies · $16.20 in 2025
The $16.20 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $68.61 · 2022: $55.80 · 2023: $96.15 · 2024: $93.84 · 2025: $16.20.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $156 · Education: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $156.19 |
| Education | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $60.17 | 2023 | Avvigo Guidance System, Opticross |
| Shockwave Medical, INC | $55.80 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $54.04 | 2021 | |
| Abbott Laboratories | $50.00 | 2024 | Ensite |
| Cardiva Medical, INC. | $24.86 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Astrazeneca Pharmaceuticals Lp | $20.57 | 2023 | Farxiga |
| Janssen Pharmaceuticals, INC | $18.98 | 2024 | Xarelto |
| Philips North America LLC | $16.20 | 2025 | Omniwire |
| Pfizer INC. | $15.41 | 2023 | |
| Medtronic, INC. | $14.57 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Spirawk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.